The difficulties that we encountered to keep stable SUM159PT clones overexpressing CASD1 or to generate clones stably depleted for CASD1 by shRNA (data not shown) raise questions concerning the choice of BC cells that were used for the study and the methods employed to generate stable clones. The gene discussed is CASD1; the disease is breast cancer.